Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Q2 2024 vs. Q1 2024
How the institutions holding Biofrontera Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 11 | 12 | +1 |
| Shares | 1.09M | 1.17M | +83.2K (+7.7%) |
| Value | $1.67M | $1.05M | −$616.3K (−37.0%) |
New holders (4)
Institutions that held Biofrontera Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 17,542 | $15.8K | 0.00% |
| UBS Group AG | 10,017 | $8.99K | 0.00% |
| Bank of America Corp | 24 | $22 | 0.00% |
| Morgan Stanley | 6 | $5 | 0.00% |
Sold out (3)
Institutions that held Biofrontera Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| XTX Topco Ltd | 12,185 | $18.8K |
| Renaissance Technologies LLC | 10,221 | $16.0K |
| HRT Financial LP | 10,639 | $16.0K |